Pharsight

Skyla patents expiration

SKYLA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5785053 BAYER HLTHCARE Inserter for the positioning of an intrauterine device
Dec, 2015

(8 years ago)

US7252839 BAYER HLTHCARE Delivery system and a manufacturing process of a delivery system
Nov, 2023

(5 months ago)

US11628088 BAYER HLTHCARE Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection
Feb, 2027

(2 years from now)

US9615965 BAYER HLTHCARE Inserter
Sep, 2029

(5 years from now)

US10561524 BAYER HLTHCARE Inserter
Sep, 2029

(5 years from now)

US9668912 BAYER HLTHCARE Inserter
Apr, 2031

(6 years from now)

US10987244 BAYER HLTHCARE Inserter
Apr, 2031

(6 years from now)

Skyla is owned by Bayer Hlthcare.

Skyla contains Levonorgestrel.

Skyla has a total of 7 drug patents out of which 2 drug patents have expired.

Expired drug patents of Skyla are:

  • US5785053
  • US7252839

Skyla was authorised for market use on 09 January, 2013.

Skyla is available in intrauterine device;intrauterine dosage forms.

Skyla can be used as a method of positioning an intrauterine system by holding an inserter handle with one hand, advancing the inserter through the cervix and into the uterus, and retracting a slider on the handle to release the intrauterine system, a method of positioning an intrauterine system (ius) by determining a depth of the uterus, holding an inserter handle with one hand, inserting the ius into the uterus, and retracting a slider on the handle to release the ius into the uterus.

The generics of Skyla are possible to be released after 01 April, 2031.

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jan 09, 2016

Drugs and Companies using LEVONORGESTREL ingredient

Market Authorisation Date: 09 January, 2013

Treatment: A method of positioning an intrauterine system by holding an inserter handle with one hand, advancing the inserter through the cervix and into the uterus, and retracting a slider on the handle to rele...

Dosage: INTRAUTERINE DEVICE;INTRAUTERINE

More Information on Dosage

SKYLA family patents

Family Patents